Harvard Bioscience, Inc. (HBIO)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$6.02
+1.18%
Mkt Cap $21.73M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
-0.3%
Consensus $6.00 vs current $6.02